BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7861202)

  • 1. [Experimental evaluation of antibiotics as immunomodulators].
    Labro MT
    J Chemother; 1994 Aug; 6 Suppl 3():11-5. PubMed ID: 7861202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response to antibiotics in patients with secondary immunodeficiencies].
    Meroni PL
    J Chemother; 1994 Aug; 6 Suppl 3():16-8. PubMed ID: 7861203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Do effects of biological response modifiers in vitro correspond to clinical results?].
    Graninger W; Wenisch C; Parshalk B
    J Chemother; 1994 Aug; 6 Suppl 3():23-8. PubMed ID: 7861205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolides and the immune system.
    McDonald PJ; Pruul H
    Scand J Infect Dis Suppl; 1992; 83():34-40. PubMed ID: 1488627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interactions between antibiotics and immune defenses. Conclusions].
    Gialdroni Grassi G
    J Chemother; 1994 Aug; 6 Suppl 3():31-2. PubMed ID: 7861208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Microbiological aspects of antibiotics with immunomodulating action].
    Schito GC; Debbia EA; Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A
    J Chemother; 1994 Aug; 6 Suppl 3():19-22. PubMed ID: 7861204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial agents as biological response modifiers (BRM) and chrono-immunomodulation: an emerging relationship.
    Dammacco F; Halberg F; Carandente F
    Chronobiologia; 1988; 15(1-2):25-39. PubMed ID: 3046851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties.
    Labro MT
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():37-47. PubMed ID: 2074251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beneficial effects of the combination of antibiotics and immunomodulating lipopeptides].
    Floc'h F; Poirier J
    Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1454-6. PubMed ID: 3325915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interactions between antibiotics and immune defenses. Introduction].
    Periti P
    J Chemother; 1994 Aug; 6 Suppl 3():3-5. PubMed ID: 7861207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics and their interaction with the host defense system in vivo.
    Grassi GG; Fietta A
    J Chemother; 1991 Jan; 3 Suppl 1():112-5. PubMed ID: 12041742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of antibiotics with phagocytes in vitro.
    Carlone NA; Cuffini AM; Tullio V; Cavallo G
    J Chemother; 1991 Jan; 3 Suppl 1():98-104. PubMed ID: 12041799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evaluation of cefodizime: a unique molecule among cephalosporins.
    Labro MT
    Infection; 1992; 20 Suppl 1():S45-7. PubMed ID: 1526677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics and neutrophil function--potential immunomodulating activities.
    Gemmell CG
    J Antimicrob Chemother; 1993 Feb; 31 Suppl B():23-33. PubMed ID: 8449843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and differentiated treatment of secondary immunodeficiencies].
    Kolesnikov AP; Khabarov AS; Kozlov VA
    Ter Arkh; 2001; 73(4):55-9. PubMed ID: 11494450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefodizime: a third generation cephalosporin with immunomodulating properties.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():1-134. PubMed ID: 2074242
    [No Abstract]   [Full Text] [Related]  

  • 19. [Enhancement of the activity of antitubercular agents with other antimicrobial agents].
    Vinogradova TI
    Probl Tuberk; 1994; (3):59-62. PubMed ID: 7937678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among antibiotics, bacteria and the human immune system: the clinical relevance of in vitro testing.
    Bergogne-Berezin E
    J Chemother; 1997 May; 9 Suppl 1():109-15. PubMed ID: 9248969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.